Cargando…

Alterations in Evoked Otoacoustic Emissions by the Use of Meglumine Antimoniate in American Tegumentary Leishmaniasis Patients

INTRODUCTION: Tegumentary Leishmaniasis (TL) is a neglected, non-contagious, infectious disease, caused by different protozoa species of the Leishmania genus that affects skin and mucous membranes. Meglumine Antimoniate (MA), the first drug of choice for TL treatment in Brazil, has already been asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira Bezerra, Débora Cristina, Oliveira de Barcelos, Renata, Carvalho de Castro, Ellen, Jardim Duarte, Claudia Cristina, de Vasconcellos Carvalhaes Oliveira, Raquel, Salgado de Sousa Torraca, Tania, de Araújo-Melo, Maria Helena, Pereira Bom Braga, Frederico, Ramos Ferreira Terceiro, Benivaldo, do Nascimento Brahim Paes, Lúcia Regina, de Oliveira Schubach, Armando, Valete-Rosalino, Cláudia Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207536/ https://www.ncbi.nlm.nih.gov/pubmed/28045920 http://dx.doi.org/10.1371/journal.pone.0168492

Ejemplares similares

FIRST REPORT ON OTOTOXICITY OF MEGLUMINE ANTIMONIATE
por: Valete-Rosalino, Cláudia Maria, et al.
Publicado: (2014)

RESOLUTION OF CUTANEOUS LEISHMANIASIS AFTER ACUTE ECZEMA DUE TO INTRALESIONAL MEGLUMINE ANTIMONIATE
por: Vasconcellos, Erica de Camargo Ferreira e, et al.
Publicado: (2014)

Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)
por: Brahim, Lucia Regina, et al.
Publicado: (2017)

FACTORS ASSOCIATED TO ADHERENCE TO DIFFERENT TREATMENT SCHEMES WITH MEGLUMINE ANTIMONIATE IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS
por: Ribeiro, Madelon Novato, et al.
Publicado: (2014)

An old drug and different ways to treat cutaneous leishmaniasis: Intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil
por: Oliveira-Ribeiro, Carla, et al.
Publicado: (2021)

Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study
por: Gagini, Thalita, et al.
Publicado: (2017)

Voice Disorders in Mucosal Leishmaniasis
por: Ruas, Ana Cristina Nunes, et al.
Publicado: (2014)

Is There Any Difference in the In Situ Immune Response in Active Localized Cutaneous Leishmaniasis That Respond Well or Poorly to Meglumine Antimoniate Treatment or Spontaneously Heal?
por: Leite-Silva, Jéssica, et al.
Publicado: (2023)

Oral Manifestations in the American Tegumentary Leishmaniasis
por: da Costa, Daniel Cesar Silva, et al.
Publicado: (2014)

American tegumentary leishmaniasis caused by Leishmania (Viannia) braziliensis: assessment of parasite genetic variability at intra- and inter-patient levels
por: Oliveira, Fernanda S, et al.
Publicado: (2013)

Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial
por: Lago, Jamile, et al.
Publicado: (2023)

Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial
por: Lago, Jamile, et al.
Publicado: (2023)

PANCREATIC TOXICITY AS AN ADVERSE EFFECT INDUCED BY MEGLUMINE ANTIMONIATE THERAPY IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS
por: LYRA, Marcelo Rosandiski, et al.
Publicado: (2016)

In Vitro Sensitivity of Paired Leishmania (Viannia) braziliensis Samples Isolated before Meglumine Antimoniate Treatment and after Treatment Failure or Reactivation of Cutaneous Leishmaniasis
por: Baptista, Cibele, et al.
Publicado: (2015)

Geospatial analysis of tegumentary leishmaniasis in Rio de Janeiro state, Brazil from 2000 to 2015: Species typing and flow of travelers and migrants with leishmaniasis
por: Miranda, Luciana de Freitas Campos, et al.
Publicado: (2019)

Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area
por: Barroso, Daniel Holanda, et al.
Publicado: (2022)

Factors Associated with Clinical and Topographical Features of Laryngeal Tuberculosis
por: Reis, João Gustavo Corrêa, et al.
Publicado: (2016)

Severity of tegumentary leishmaniasis is not exclusively associated with Leishmania RNA virus 1 infection in Brazil
por: Pereira, Luiza de Oliveira Ramos, et al.
Publicado: (2013)

Effects of Meglumine Antimoniate Treatment on Cytokine Production in a Patient with Mucosal Leishmaniasis and Chagas Diseases Co-Infection
por: Rezende-Oliveira, Karine, et al.
Publicado: (2020)

MONTENEGRO SKIN TEST AND AGE OF SKIN LESION AS PREDICTORS OF TREATMENT FAILURE IN CUTANEOUS LEISHMANIASIS
por: Antonio, Liliane de Fátima, et al.
Publicado: (2014)

Evidence for Tissue Toxicity in BALB/c Exposed to a Long-Term Treatment with Oxiranes Compared to Meglumine Antimoniate
por: Oliveira, Luiz Filipe Gonçalves, et al.
Publicado: (2017)

Are Neutrophil Extracellular Traps Playing a Role in the Parasite Control in Active American Tegumentary Leishmaniasis Lesions?
por: Morgado, Fernanda Nazaré, et al.
Publicado: (2015)

Clinical and laboratory profiles of patients with early spontaneous healing in cutaneous localized leishmaniasis: a historical cohort study
por: Oliveira-Ribeiro, Carla, et al.
Publicado: (2017)

Reactivation of cutaneous and mucocutaneous tegumentary leishmaniasis in rheumatoid arthritis patients: an emerging problem?
por: de Souza, Regina Maia, et al.
Publicado: (2017)

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis
por: Martins, Sofia Sales, et al.
Publicado: (2021)

Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil
por: Saheki, Mauricio Naoto, et al.
Publicado: (2017)

Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
por: Vargas, Deninson Alejandro, et al.
Publicado: (2019)

Hoigne Syndrome Caused by Intralesional Meglumine Antimoniate
por: Guarneri, Claudio, et al.
Publicado: (2017)

Dual Role of Insulin-Like Growth Factor (IGF)-I in American Tegumentary Leishmaniasis
por: de O Mendes-Aguiar, Carolina, et al.
Publicado: (2021)

Tissue distribution of residual antimony in rats treated with multiple doses of meglumine antimoniate
por: Coelho, Deise Riba, et al.
Publicado: (2014)

Pharmacokinetics of neutron-irradiated meglumine antimoniate in Leishmania amazonensis-infected BALB/c mice
por: Borborema, Samanta Etel Treiger, et al.
Publicado: (2019)

Study of otoacoustic emissions during the female hormonal cycle
por: Arruda, Priscila Oliveira, et al.
Publicado: (2015)

Evoked otoacoustic emissions in workers exposed to noise: A review
por: Alcarás, Patrícia Arruda de Souza, et al.
Publicado: (2012)

Complementary exams in the diagnosis of american tegumentary leishmaniasis
por: Gomes, Ciro Martins, et al.
Publicado: (2014)

Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice
por: Borborema, Samanta Etel Treiger, et al.
Publicado: (2013)

Study on suppression of otoacoustic emissions: lateral domain
por: Massola de Oliveira, Jerusa Roberta, et al.
Publicado: (2015)

Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis
por: Brito, Nayara C., et al.
Publicado: (2019)

Neutrophil Activation: Influence of Antimony Tolerant and Susceptible Clinical Strains of L. (V.) panamensis and Meglumine Antimoniate
por: Fernández, Olga Lucía, et al.
Publicado: (2021)

The Study of Otoacoustic Emissions and the Suppression of Otoacoustic Emissions in Subjects with Tinnitus and Normal Hearing: An Insight to Tinnitus Etiology
por: Serra, Lucieny, et al.
Publicado: (2014)

Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis
por: Berenguer, Diana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e4j70m01170ofp7e2qo1k6da4t